Anuh Pharma Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and a relevant BSE circular. The trading window will be shut for all insiders, designated persons, and their immediate relatives starting from Thursday, January 01, 2026. The closure will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter ended December 31, 2025. Consequently, all individuals covered under the company's Code of Conduct for Prevention of Insider Trading are advised against trading in Anuh Pharma's securities during this period.